Meghmani Organics reported a consolidated net profit of ₹48.2 crore for Q1FY27, marking a 280% year-on-year increase, while standalone net profit grew 42% to ₹57.6 crore. The significant profitability improvement was driven by an expansion in consolidated EBITDA margins to 18% from 10.9% in the previous year, despite an 11.5% decline in consolidated revenue to ₹542.8 crore. This divergence highlights the company’s strategic shift towards optimizing product mix and disciplined pricing to protect bottom-line performance amidst softer demand.

The Board of Directors approved the unaudited financial results on July 29, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results were reviewed by the Audit Committee and subjected to limited review by statutory auditors Mukesh M. Shah & Co., Chartered Accountants. During the subsequent earnings conference call held on July 30, 2026, management provided further context on operational challenges, segment-wise outlooks, and capital allocation strategies.

Financial Performance Highlights

Standalone revenue from operations declined 12% year-on-year to ₹522.9 crore, primarily due to subdued demand across key export markets and domestic regions. However, operational leverage improved significantly. Standalone EBITDA grew 16% to ₹93.7 crore, with margins expanding to 17.9% from 13.6% in Q1FY26. On a consolidated basis, EBITDA grew 46% to ₹97.9 crore. The improvement in finance costs contributed to the net profit surge, driven by reduced mark-to-market (MTM) losses on foreign currency debt and active debt repayment.

Segment-Wise Breakdown

The Crop Protection segment remained the primary revenue driver, contributing approximately 75% of overall revenue with ₹391.6 crore and an EBITDA of ₹77.8 crore. Its EBITDA margin stood at 19.9%, with capacity utilization at 63%. Management indicated that volume growth in this segment is expected to be double-digit over the next two to three years, targeting industry-average margins of 15–17% or higher.

The Pigments segment generated ₹131.3 crore in revenue, constituting ~25% of the total, with an EBITDA of ₹15.9 crore and a margin of 12.1%. Capacity utilization for Pigments stood at 39%. Chairman Ankit Patel clarified that the company does not aim for maximum utilization in this segment due to overcapacity in the market, instead targeting annualized revenue of ₹550–600 crore and maintaining EBITDA margins near 10%. Operations in Titanium Dioxide remain suspended due to commercial unviability arising from elevated raw material costs, specifically sulfuric acid prices which have increased eight- to ten-fold globally.

Corporate Developments and Capital Allocation

The Scheme of Amalgamation of Kilburn Chemicals Limited and Meghmani Crop Nutrition Limited into Meghmani Organics Limited received approval from the National Company Law Tribunal (NCLT), Ahmedabad Bench. Shareholder and creditor votes were held between June 3 and June 5, 2026. The amalgamation aims to simplify the group structure, derive operational synergies, and eliminate duplicate compliances without impacting consolidated financial metrics, as it involves wholly-owned subsidiaries using the pooling of interest method.

Regarding balance sheet strength, standalone total debt stood at ₹555 crore (₹474 crore short-term, ₹81 crore long-term) with a debt-to-equity ratio of 0.31. Consolidated debt was ₹732 crore (₹477 crore short-term, ₹256 crore long-term) with a debt-to-equity ratio of 0.46. The company repaid approximately ₹32 crore in debt during Q1FY27 and expects to repay around ₹130 crore annually, leveraging an average debt cost of 7% to reduce finance costs further.

What the Numbers Show

The near-doubling of the standalone EBITDA margin despite a 12% revenue decline indicates strong operational efficiency gains through better price realization and favorable product mix. Management explicitly corrected market misconceptions regarding peak revenue guidance, stating that while Crop Protection could reach ₹2,500–3,000 crore at 85–90% utilization, current strategy prioritizes profitability over top-line growth in volatile markets. The suspension of Titanium Dioxide operations, which incurred a negative EBITDA of nearly ₹3 crore in Q1FY27, underscores the severe impact of global raw material inflation on specific segments, necessitating strategic pauses until cost structures normalize.

Meghmani Organics Limited will host its Q1 FY27 earnings call on Thursday, July 30, 2026, at 5:00 PM IST. The company issued the schedule pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing stakeholders of the event to discuss its recent financial results.

The conference call aims to provide clarity on the company’s performance for the first quarter of FY27. Management will address investor queries regarding operational metrics and financial health during the session.

Key Participants

The following executives will lead the discussion:

• Ankit Patel, Chairman and Managing Director
• G S Chahal, Chief Financial Officer
• Nishant Vyas, Investor Relations

Conference Details

Arihant Capital Markets Ltd is facilitating the earnings call. Investors and analysts can participate via the following channels:

Participants are advised to dial in at least 5–10 minutes prior to the scheduled start time to ensure timely connection. An Express Join link with DiamondPass™ is also available for no-wait access.

Research Coverage

Arihant Capital Markets’ research team will be available for queries:

• Abhishek Jain, Director – Institutional Research
• Rashmi Gohil, Equity Research Analyst

The notice was signed by Ankit Natwarlal Patel, Chairman & Managing Director, on July 25, 2026.